Annual Total Long Term Liabilities
$74.73 M
-$287.06 M-79.34%
December 31, 2024
Summary
- As of March 2, 2025, LAB annual total long term liabilities is $74.73 million, with the most recent change of -$287.06 million (-79.34%) on December 31, 2024.
- During the last 3 years, LAB annual total long term liabilities has fallen by -$56.32 million (-42.98%).
- LAB annual total long term liabilities is now -82.55% below its all-time high of $428.33 million, reached on December 31, 2022.
Performance
LAB Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
N/A
December 31, 2024
Summary
- LAB quarterly total long term liabilities is not available.
Performance
LAB Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
LAB Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -79.3% | - |
| 3 y3 years | -43.0% | - |
| 5 y5 years | -4.7% | - |
LAB Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -82.5% | at low | ||
| 5 y | 5-year | -82.5% | at low | ||
| alltime | all time | -82.5% | +4956.0% |
Standard BioTools Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $74.73 M(-79.3%) | - |
| Sep 2024 | - | $71.59 M(-4.1%) |
| Jun 2024 | - | $74.66 M(-5.2%) |
| Mar 2024 | - | $78.80 M(-78.2%) |
| Dec 2023 | $361.79 M(-15.5%) | $361.79 M(-13.7%) |
| Sep 2023 | - | $419.20 M(-0.8%) |
| Jun 2023 | - | $422.37 M(-0.6%) |
| Mar 2023 | - | $425.02 M(-0.8%) |
| Dec 2022 | $428.33 M(+226.8%) | $428.33 M(-0.7%) |
| Sep 2022 | - | $431.49 M(-1.0%) |
| Jun 2022 | - | $435.81 M(+115.1%) |
| Mar 2022 | - | $202.65 M(+54.6%) |
| Dec 2021 | $131.05 M(-0.3%) | $131.05 M(-3.3%) |
| Sep 2021 | - | $135.56 M(+6.7%) |
| Jun 2021 | - | $127.02 M(-1.3%) |
| Mar 2021 | - | $128.73 M(-2.1%) |
| Dec 2020 | $131.46 M(+67.7%) | - |
| Dec 2020 | - | $131.46 M(+2.5%) |
| Sep 2020 | - | $128.21 M(+15.2%) |
| Jun 2020 | - | $111.28 M(-1.8%) |
| Mar 2020 | - | $113.36 M(+44.6%) |
| Dec 2019 | $78.38 M(-59.6%) | - |
| Dec 2019 | - | $78.38 M(+6.7%) |
| Sep 2019 | - | $73.42 M(-0.6%) |
| Jun 2019 | - | $73.83 M(-1.6%) |
| Mar 2019 | - | $75.02 M(-61.3%) |
| Dec 2018 | $193.95 M(-13.0%) | $193.95 M(+1.5%) |
| Sep 2018 | - | $191.01 M(+1.8%) |
| Jun 2018 | - | $187.62 M(+0.1%) |
| Mar 2018 | - | $187.42 M(-15.9%) |
| Dec 2017 | $222.94 M | $222.94 M(+0.9%) |
| Sep 2017 | - | $221.04 M(+0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $220.45 M(-1.0%) |
| Mar 2017 | - | $222.68 M(-0.4%) |
| Dec 2016 | $223.66 M(-0.6%) | $223.66 M(-0.4%) |
| Sep 2016 | - | $224.53 M(-0.4%) |
| Jun 2016 | - | $225.46 M(+0.2%) |
| Mar 2016 | - | $224.94 M(-0.1%) |
| Dec 2015 | $225.07 M(-1.2%) | $225.07 M(-0.8%) |
| Sep 2015 | - | $226.88 M(-0.0%) |
| Jun 2015 | - | $226.98 M(-0.3%) |
| Mar 2015 | - | $227.67 M(-0.0%) |
| Dec 2014 | $227.75 M(+8831.6%) | $227.75 M(-0.3%) |
| Sep 2014 | - | $228.53 M(-0.0%) |
| Jun 2014 | - | $228.61 M(-1.3%) |
| Mar 2014 | - | $231.56 M(+8980.6%) |
| Dec 2013 | $2.55 M(+72.5%) | $2.55 M(+16.7%) |
| Sep 2013 | - | $2.19 M(+11.9%) |
| Jun 2013 | - | $1.95 M(+24.0%) |
| Mar 2013 | - | $1.58 M(+6.6%) |
| Dec 2012 | $1.48 M(-34.5%) | $1.48 M(+12.7%) |
| Sep 2012 | - | $1.31 M(+5.2%) |
| Jun 2012 | - | $1.25 M(+21.6%) |
| Mar 2012 | - | $1.02 M(-54.6%) |
| Dec 2011 | $2.26 M(-98.8%) | $2.26 M(-40.4%) |
| Sep 2011 | - | $3.79 M(-32.2%) |
| Jun 2011 | - | $5.59 M(-24.5%) |
| Mar 2011 | - | $7.41 M(-96.2%) |
| Dec 2010 | $195.46 M(-1.6%) | $195.46 M(+1515.9%) |
| Sep 2010 | - | $12.10 M(-93.9%) |
| Dec 2009 | $198.64 M(+9.0%) | $198.64 M(+9.0%) |
| Dec 2008 | $182.17 M(+5.0%) | $182.17 M(+1.9%) |
| Jun 2008 | - | $178.84 M(+3.1%) |
| Dec 2007 | $173.53 M(+28.1%) | $173.53 M |
| Dec 2006 | $135.51 M | - |
FAQ
- What is Standard BioTools annual total long term liabilities?
- What is the all time high annual total long term liabilities for Standard BioTools?
- What is Standard BioTools annual total long term liabilities year-on-year change?
- What is the all time high quarterly long term liabilities for Standard BioTools?
What is Standard BioTools annual total long term liabilities?
The current annual total long term liabilities of LAB is $74.73 M
What is the all time high annual total long term liabilities for Standard BioTools?
Standard BioTools all-time high annual total long term liabilities is $428.33 M
What is Standard BioTools annual total long term liabilities year-on-year change?
Over the past year, LAB annual total long term liabilities has changed by -$287.06 M (-79.34%)
What is the all time high quarterly long term liabilities for Standard BioTools?
Standard BioTools all-time high quarterly total long term liabilities is $435.81 M